News

Read our new publication in Cell in collaboration with the international Biomarkers of Aging Consortium.

EUTOPS postdoctoral researcher Chiara Herzog has received the Ernst Brandl Prize of €4,000 for her work on the development and validation of a novel epigenetic test – the WID-qEC test – for the early detection of endometrial cancer. Chiara is an integral member of the EUTOPS team, working on computational aspects of epigenetics in cancer development and prevention and in ageing research.

A new publication from Professor Martin Widschwendter and the EUTOPS team in the International Journal of Cancer describes the development of cervical cancer as a result of Human Papilloma Virus (HPV) infection.

The EUTOPS team presents four publications demonstrating that DNA methylation signature assessment using methylation array analysis in cervical screening samples detects and likely predicts the risk for all four major women’s cancers: breast, ovarian, womb and cervical cancer.

A new publication from Professor Martin Widschwendter and the EUTOPS team in Genome Medicine describes a new molecular test that can identify 55% of those with a normal cervical smear result who will go on to develop advanced cell changes or cancer within 4 years.

With the LIFE and SUN Tyrol studies, we are launching two large-scale investigations to test interval fasting, exercise and stress reduction for their health-promoting effects (LIFE Tyrol) and to optimize smoking cessation (SUN Tyrol).

Our paper describing a new test that accurately identifies women with womb cancer appears in Journal of Clinical Oncology today.

Our paper describing individualised breast cancer prevention and risk monitoring using antiprogestins and the epigenetic WID-Breast29 index appears in Genome Medicine today.